Foundation Medicine Inc (FMI) Drops 7.22% on January 04

Equities Staff |

Foundation Medicine Inc (FMI) was one of the Russell 2000's biggest losers for Monday January 04 as the stock slid 7.22% to $19.54, a loss of $-1.52 per share. Starting at an opening price of $20.52 a share, the stock traded between $19.52 and $20.65 over the course of the trading day. Volume was 340,400 shares over 2,952 trades, against an average daily volume of 329,022 shares and a total float of 34.45 million.

The losses send Foundation Medicine Inc down to a market cap of $673.18 million. In the last year, Foundation Medicine Inc has traded between $54.28 and $15.58, and its 50-day SMA is currently $18.97 and 200-day SMA is $28.99.

Foundation Medicine Inc is a commercial-stage company. The Company is a molecular information company focused on fundamentally changing the way in which patients with cancer are evaluated and treated.

Foundation Medicine Inc is based out of Cambridge, MA and has some 293 employees. Its CEO is Michael J. Pellini.

For a complete fundamental analysis analysis of Foundation Medicine Inc, check out Equities.com’s Stock Valuation Analysis report for FMI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Broadway Gold Mining Ltd.

Broadway Gold Mining Ltd is engaged in the exploration of mineral resources. The Company owns a 100% interest in the Madison Gold and Copper Mine located in Southwestern Montana.

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…